Knowledge Bank

Artificial intelligence is revolutionizing healthcare delivery by enabling personalized medicine—an individualized approach to treatment tailored to each patient's unique genetic profile, molecular characteristics, lifestyle factors, and disease presentation.

Artificial intelligence is fundamentally transforming clinical practice by equipping healthcare professionals with advanced decision-support tools that analyze complex patient data, identify risk patterns, and recommend evidence-based treatment pathways with unprecedented accuracy.

Artificial intelligence is fundamentally revolutionizing the pharmaceutical industry by dramatically accelerating drug discovery timelines while simultaneously reducing development costs through advanced machine learning algorithms and predictive modeling.

The FDA has confirmed through an announcement that it has removed a limitation on the use of real-world evidence -RWE when it comes to reviews...

In an all-stock transaction, Natera, which is the cell-free DNA and precision medicine company, has gone ahead and acquired Foresight Diagnostics, which is a business...

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched by the US Food and Drug Administration - FDA which is a pilot that looks to...

The federal government has formally withdrawn the Biden-era minimum staffing mandates for nursing homes and long-term care operators, marking a significant repeal that reshapes workforce...